The Chem­istry, Food and Drugs Di­vi­sion of the Min­istry of Health (MoH) is ad­vis­ing of a vol­un­tary re­call no­tice for eight lots of Ro­bi­tussin Hon­ey CF Max Day Adult and Ro­bi­tussin Hon­ey CF Max Night­time Adult.

The re­call was is­sued by the man­u­fac­tur­er Ha­le­on, due to mi­cro­bial con­t­a­m­i­na­tion.

“Out of an abun­dance of cau­tion, the Min­istry is urg­ing per­sons who may be in pos­ses­sion of these re­called prod­ucts to dis­con­tin­ue use im­me­di­ate­ly and to re­turn the prod­uct to the place of pur­chase where pos­si­ble,” the Health Min­istry said in its ad­vi­so­ry, not­ing that it will con­tin­ue to mon­i­tor the sit­u­a­tion and ad­vise the pop­u­la­tion as nec­es­sary.

The Min­istry notes that Ro­bi­tussin is used for cough re­lief, and the Ro­bi­tussin Hon­ey CF Max Day Adult for­mu­la—four- and eight-ounce bot­tles—is reg­is­tered for sale in this coun­try.

The Min­istry warns:

“For im­muno­com­pro­mised in­di­vid­u­als, the use of these con­t­a­m­i­nat­ed prod­ucts may re­sult in ad­verse ef­fects such as fungemia or dis­sem­i­nat­ed fun­gal in­fec­tion. Al­though life-threat­en­ing in­fec­tions are un­like­ly to oc­cur in non-im­muno­com­pro­mised per­sons, the oc­cur­rence of an in­fec­tion that may re­quire med­ical in­ter­ven­tion can­not be com­plete­ly ruled out.”

_______

Ad­di­tion­al In­for­ma­tion on the re­call can be ob­tained by con­tact­ing the Of­fice of the Di­rec­tor of the Chem­istry, Food and Drugs Di­vi­sion via email at cfdd@health.gov.tt, or by phone at 217-4664 ext. 13101.